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A quantitative approach to predicting rate constants for aqueous 
racemization allows pointless stereoselective syntheses to be 
avoided. 
Andrew Ballard, Hiwa O. Ahmad,  Stefania Narduolo,  Lucy Rosa,  Nikki Chand,  David A. Cosgrove,  
Peter Varkonyi,  Nabil Asaad,  Simone Tomasi,   Niklaas J. Buurma,*   Andrew G. Leach* 
Abstract: Racemization has a large impact upon the biological 
properties of molecules but the chemical scope of compounds with 
known rate constants for racemization in aqueous conditions was 
hitherto limited. To address this remarkable blind spot, we have 
measured the kinetics for racemization of 28 compounds using 
circular dichroism and 
1
H NMR spectroscopy. We show that rate 
constants for racemization (measured by ourselves and others) 
correlate well with deprotonation energies from quantum mechanical 
(QM) and group contribution calculations. Such calculations thus 
provide predictions of the second-order rate constants for general-
base-catalyzed racemization that are usefully accurate. When 
applied to recent publications describing the stereoselective 
synthesis of compounds of purported biological value, the 
calculations reveal that racemization would be sufficiently fast to 
render these expensive syntheses pointless. 
Thalidomide racemizes in a matter of hours and yet it remains a 
poster child for enantioselective synthesis which would not have 
saved its victims.
[1]
 The status quo in enantioselective synthesis 
thus ignores the cruel blind spot that we address in this paper: 
racemization. 
Although necessary in dynamic kinetic resolution protocols,
[2,3]
 
racemization and epimerization can cause safe compounds to 
become toxic or lose efficacy,
[4–11]
 lead to misidentification of 
chiral compounds extracted from natural sources,
[12]
 etc.  
Ignoring racemization leads to wasted material and human 
resources.  
Racemization is a particular problem because its detection 
requires chiral analytical methods.
[13,14] 
Hence, few reports 
disclose rate constants for racemization under aqueous 
conditions.
[1,15–20] 
Chiral centers with certain combinations of 
substituents have been posited to be prone to general-base-
catalyzed racemization although with little supporting data.
[21–23]
  
We therefore classified stereogenic carbon atoms according to 
their attached substituents. Each substituent is identified as one 
of sixty types,
[24]
 which encompass more than 99.95% of all such 
substituents in the GOSTAR database.
[25]
 The ten most 
frequently occurring substituents are listed in Figure 1; the H 
required for general-base-catalyzed racemization is 
prominent.
[24]
 Groups labelled * were selected for experimental 
study. 
Based on prevalence, earlier work,
[21–23]
 and chemical intuition, 
several compounds were selected for detailed kinetic studies.
[26–
28]
 The rate constants for general-base-catalyzed racemization 
were derived for a range of 11 arylglycine derivatives (1, 2 and 
3), 12 hydantoins (4, 5 and 6) and 5 thiohydantoins (7 and 8). 
Briefly, at several buffer concentrations, circular dichroism 
spectroscopy (CD) followed the decrease in ellipticity and/or 
1
H 
NMR spectroscopy the incorporation of D from deuterated 
buffers. The pseudo-first-order rate constants for these 
processes were corrected for hydrolysis side reactions if 
required.
[24]
 Plotting the first-order rate constants for 
racemization or H/D exchange against the concentration of the 
basic component of the buffer yielded the second-order rate 
constants for general-base-catalyzed racemization. These were 
corrected for reaction temperature and substrate protonation 
state.
[24]
 
 
 
Figure 1. The ten substituents appearing most frequently adjacent to carbon 
stereogenic centers in the GOSTAR database. Alk = alkyl, C = carbon-linked 
alkyl or aromatic and X = any group. * = selected for experimental study. 
For predictive modeling, a mechanistic understanding is 
beneficial. Racemization of the stereogenic centers studied here 
could occur by either an SE1 or an SE2 mechanism. For 
hydantoins (e.g. 4-6) both the SE1 and SE2 mechanisms have 
been proposed previously,
[18,29]
 but we have shown that these 
reactions occur via the SE1 mechanism.
[30]
 Further, Hammett 
plots show a better correlation with σ
–
 than σ suggesting that a 
negative charge is formed on the stereogenic center in the rate-
determining step of the racemization reaction, in line with an SE1 
mechanism.
[24]
 The experimental data were correlated with 
deprotonation energies (∆∆G(R1,R2,R3), Scheme 1) from 
B3LYP/6-31+G** calculations incorporating aqueous solvation 
via the PCM protocol.
[24]
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general-base-catalyzed racemization, kgb, correlate well with 
∆∆G(R1,R2,R3) for 1-3 and 4-8.
[24]
 
 
 
The set of compounds was supplemented with literature data,
[24]
 
leading to the relationship with ∆∆G(R1,R2,R3) shown at the top 
of Figure 2. The line of best fit has equation log(kgb) = -0.20 
×∆∆G(R1,R2,R3) -14.28, with an R
2
 value of 0.68 and root mean 
square error of 0.61, i.e. reproducing rate constants to within a 
factor of ~4. Clopidogrel is excluded from this analysis due to 
large experimental uncertainties.
[24]
 
 
Scheme 1. 
 
The computational procedure was extended to include a group-
contribution approach that is amenable to rapid analysis of chiral 
compounds and is described in the supporting information. A 
simple representative (R) of each substituent type was selected 
and ∆∆G(R1,R2,R3) computed with R1=R and R2=R3=H. These 
∆∆G(R,H,H) values indicate how much R stabilizes an adjacent 
anion. The sum ∆∆G(R1,H,H) + ∆∆G(R2,H,H) + ∆∆G(R3,H,H), for 
the three non-H substituents around a chiral carbon atom is 
referred to here as Σ∆∆G. When two or three of the groups 
provide stabilization through charge delocalization (as indicated 
in Section S7), a cross-conjugation correction is applied to 
reflect the reduced ability of the second group to stabilize the 
anion caused by the presence of the first.
[24]
  
The 35 compounds studied fall into fourteen chiral carbon atom 
types (A – N, Table 1) that have one hydrogen attached.
[1,15–19,31]
 
The second-order rate constants for general-base-catalyzed 
racemization are plotted against Σ∆∆G at the bottom of Figure 2. 
When a chiral center type is represented by more than one 
compound, the mean value of log(kgb) for all representatives was 
used and the full range of values is shown as a vertical line.  
This prevents any center type from dominating the linear fit.  
 
 
Figure 2.  Second-order rate constants for racemization under aqueous 
general-base-catalyzed conditions plotted against: computed ΔΔG(R1,R2,R3) 
values (top) and ΣΔ∆G values (bottom) . Points are shown as Top: 1a (), 1b 
(), 1c (), 1d (), 1e (), 1f (), 1g(), 1h (), 2 (), 3a (), 3b (), 4a 
(), 4b (), 4c (), 4d () 4e (), 4f (), 4g (), 5a (), 5b (), 5c (), 5f 
(), 6 (), 7a (), 7b (), 7c (), 7d (), 8 (), 9 (), 10 (), 11 (), 12 
(), 13 (), 14 (), 15 (), 16 (). Bottom: A (), B (), C (), D (), D' 
(), E (), F (), G (), H (), I (), J (), K (), L (), M () and N (). 
Clopidogrel (16) is excluded from the line fitting. 
Table 1. Stereogenic center types. 
Center 
Type 
Non-H Substituents  Representative 
compounds [Number] 
A Phenyl, Reversed 2˚ amide, Ester 1a-h [8] 
B Phenyl, Reversed 2˚ amide, 1˚ amide 2 [1] 
C 5-Membered aromatic, Reversed 2˚ 3 [2] 
-6
-5
-4
-3
-2
-1
0
-65 -63 -61 -59 -57 -55 -53 -51 -49 -47 -45
lo
g
(k
g
b
)(
∆∆G(R1,R2,R3)(/"kcal"mol
)1"
-6
-5
-4
-3
-2
-1
0
-69 -67 -65 -63 -61 -59 -57 -55 -53 -51 -49 -47 -45
lo
g
(k
g
b
)(
∑∆∆G(/"kcal"mol)1"
COMMUNICATION          
 
 
 
 
amide, Ester 
D/D’ Alkyl, Reversed 2˚ amide, Acidic 2˚ amide D = 4a-g, 5a-c+f [11] 
D' = 14 [1] 
E Phenyl, Reversed 2˚ amide, Acidic 2˚ 
amide 
6 [1] 
F Alkyl, Aminothiooxo imide, Acidic 2˚ 
amide 
7a-d [4] 
G Alkyl, Reversed 2˚ thioamide, Acidic 2˚ 
amide 
8 [1] 
H Ketone, Dialkyl 3˚ amine, Alkyl 9 [1] 
I Ketone, 1˚ amine, Alkyl 10 [1] 
J Carboxylic acid, 5-Membered aromatic, 
Alkyl 
11 [1] 
K Thioether, Alkyl, Acidic 2˚ amide 12 [1] 
L Imide, Alkyl, Acidic 2˚ amide 13 [1] 
M Phenyl, Phenyl, 5-Membered aromatic 15 [1] 
N Ester, Dialkyl tertiary amine, Phenyl 16 [1] 
 
For the phenylglycine esters (A), substituent effects can cause 
up to a log unit variation from the line of best fit. This is likely to 
be representative of general substituent effects.
[24]
 Grouping 
five-membered aromatic rings together (C) masks variation of 
1.6 log units, likely reflecting the more direct influence of 
heteroatoms in aromatic rings. A relatively diverse set of alkyl 
substituents in the 5-position on a hydantoin ring (group D) or 
thiohydantoin (F) causes little variation in rate constants for 
racemization. In general, variation caused by substitution or 
structural variation within classes is less than two orders of 
magnitude and typically less than one order of magnitude. 
At the bottom of Figure 2, two subgroups are apparent: those 
involving a cyclic anion with the potential to be aromatic and 
those that do not. For the non-aromatic set (shown in red) a line 
of best fit with equation log(kgb) = -0.11× Σ∆∆G -9.81 was found 
(R
2
 = 0.78 and RMSE = 0.40 log units) and for the aromatic 
anion set (shown in blue) the line of best fit has equation log(kgb) 
= -0.26× Σ∆∆G - 16.95 (R
2
 = 0.92 and RMSE = 0.39 log units). 
The RMSE for all compounds computed individually is 0.64 for 
non-aromatic anions (excluding clopidogrel) and 0.37 for 
aromatic anions i.e. predictions are typically within 5-fold. 
Although not a perfect guide, the group contribution approach 
provides an easily applied, useful and rapid filtering that can 
even be used for very large databases.  
For the particular example of chiral pharmaceuticals, our 
analysis can be applied to predict half lives of racemization in 
physiological conditions. The rate constants for racemization of 
thalidomide at different phosphate buffer concentrations 
compared to that in blood suggest that, in terms of availability of 
catalytically active general bases, blood is approximately 
equivalent to a 0.15 M phosphate buffer at pH 7.2. Therefore, 
with kgb predicted by the QM or group contribution method, the 
required half lives can be predicted.
[1]
 
A comprehensive workflow has now arisen: rapid analysis with a 
group contribution based method can trigger quantum 
mechanical calculations, which in turn can trigger an 
experimental protocol (Figure 3). Compounds at high risk of 
racemization can be avoided and racemization risk can be 
suppressed by design.   
 
 
Figure 3. Workflow for identifying compounds at risk of racemization, in 
parentheses is the typical time taken to process one compound at each step. 
To illustrate the degree to which racemization in aqueous 
conditions is an overlooked problem, we have surveyed recent 
editions of leading chemistry journals, using our knowledge of 
the group contributions, to identify several articles envisaging 
biological applications. This was not an exhaustive search. 
Compounds described were subject to group contribution 
calculations. It is disappointing to reveal (Table 2) that liability to 
racemize under physiological conditions is more commonplace 
than would be possible if it were properly understood and 
controlled, as many chemists seem to believe. 
Table 2. Examples of potentially pointless stereoselective syntheses from 
recent literature. 
Reference Representative compound ΣΔ∆G 
(kcal/mol) 
Predicted % 
racemized 
within 24 
hours 
[32] 
 
-48.8 28 % 
[33] 
 
-50.7 40 % 
[34]  
 
-54.1 70 % 
[35]  
 
-46.9 19 % 
 
In summary, we describe an approach to quantitative predictions 
of racemization risk that is generally applicable and allows 
synthetic chemists to avoid racemization-prone targets or 
COMMUNICATION          
 
 
 
 
understand erosion of e.e.  It allows users of chiral compounds, 
as pharmaceuticals or otherwise, to assess the risk of them 
becoming mixtures of compounds. 
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